News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>JPM Adds DAMAI ENT (01060.HK) TP to $1.2, Downgrades MAOYAN ENT (01896.HK) to Neutral
DAMAI ENT (01060.HK) and MAOYAN ENT (01896.HK) posted a stark contrast in stock returns this year, with DAMAI ENT soaring by 91% and MAOYAN ENT dipping by 10%, compared to a 17% in...
Reset
Send
The window will close in 5 seconds
<Research>JPM Adds DAMAI ENT (01060.HK) TP to $1.2, Downgrades MAOYAN ENT (01896.HK) to Neutral
Close
Recommend
13
Positive
19
Negative
5
 
SHORT SELL
 
STOCK INFO

DAMAI ENT (01060.HK)  +0.050 (+5.319%)    Short selling $11.00M; Ratio 4.820%   and MAOYAN ENT (01896.HK)  +0.300 (+4.208%)    Short selling $3.73M; Ratio 15.601%   posted a stark contrast in stock returns this year, with DAMAI ENT soaring by 91% and MAOYAN ENT dipping by 10%, compared to a 17% increase in the MSCI China Index, JPMorgan released a research report saying. The broker attributed this mainly to DAMAI ENT's active development in IP commercialization and offline event ticketing business.

Given DAMAI ENT's strategic focus and revenue risks differing from MAOYAN ENT, JPMorgan projected DAMAI ENT's performance to continue outperforming MAOYAN ENT, and kept rating at Overweight for DAMAI ENT. The broker also added its target price from $0.59 to $1.2.

JPMorgan downgraded MAOYAN ENT from Overweight to Neutral, and trimmed its target price from $12 to $6.8.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-08 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.